Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-04-19 | Mr. Stapley holds a B.Sc. (Honors) from The University of Reading and is a member of the Institute of Chartered Accountants in England and Wales. |
| 2017-04-18 | Mr. Stapley holds a B.Sc. (Honors) from The University of Reading (England) and is a member of the Institute of Chartered Accountants in England and Wales. He has held senior finance roles at Illumina, Pfizer, Alcatel Lucent, and Cadence Design Systems, Inc. |
| 2018-04-18 | Mr. Stapley is currently the executive vice president, strategy and corporate development, for Illumina, Inc. Previously, Mr. Stapley served as Illumina's chief administrative officer with responsibility for all general and administrative functions. Prior to that, he served as senior vice president and chief financial officer of Illumina. He is also a member of Illumina’s executive management team, which is responsible for directing all aspects of the company’s strategy, planning and operations. |
| 2019-04-17 | He holds a B.Sc. (Honors) from The University of Reading (England) and is a member of the Institute of Chartered Accountants in England and Wales. |
| 2020-04-24 | Mr. Stapley holds a B.Sc. (Honors) from The University of Reading (England) and is a member of the Institute of Chartered Accountants in England and Wales. We believe Mr. Stapley’s extensive experience in senior finance positions with public companies qualifies him to serve on our Board of Directors. |
| 2021-04-22 | He was also a member of Illumina’s executive management team, responsible for directing all aspects of the company’s strategy, planning and operations... He also serves on the boards of Immunis.AI, a privately held immunogenomics company... Cybersecurity |
| 2022-04-19 | Mr. Stapley has served as a member of our Board of Directors since 2014. He is the CEO and a member of the board of directors of Veracyte Inc. ... He holds a B.Sc. (Honors) from The University of Reading (England) and is a member of the Institute of Chartered Accountants in England and Wales. |
| 2023-04-18 | Chief Executive Officer, Veracyte, Inc. (2021 to current); B.Sc (Honors), The University of Reading; no mention of software or technical skills. |
| 2024-04-16 | Chief Executive Officer, Veracyte, Inc.; Executive Vice President, Strategy and Corporate Development, Illumina, Inc.; B.Sc (Honors), The University of Reading. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22